DK143501C - Analogifremgangsmaade til fremstilling af beta-receptorblokerende derivater af 2-hydroxy-3-aminopropan eller terapeutisk anvendelige salte deraf - Google Patents

Analogifremgangsmaade til fremstilling af beta-receptorblokerende derivater af 2-hydroxy-3-aminopropan eller terapeutisk anvendelige salte deraf

Info

Publication number
DK143501C
DK143501C DK80774A DK80774A DK143501C DK 143501 C DK143501 C DK 143501C DK 80774 A DK80774 A DK 80774A DK 80774 A DK80774 A DK 80774A DK 143501 C DK143501 C DK 143501C
Authority
DK
Denmark
Prior art keywords
aminopropan
analogue
beta
hydroxy
preparation
Prior art date
Application number
DK80774A
Other languages
Danish (da)
English (en)
Other versions
DK143501B (da
Inventor
J Frei
K A Jaeggi
F Ostermayer
H Schroeter
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH244473A external-priority patent/CH584209A5/de
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Priority to DK364180A priority Critical patent/DK364180A/da
Publication of DK143501B publication Critical patent/DK143501B/da
Application granted granted Critical
Publication of DK143501C publication Critical patent/DK143501C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/69Two or more oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK80774A 1973-02-20 1974-02-15 Analogifremgangsmaade til fremstilling af beta-receptorblokerende derivater af 2-hydroxy-3-aminopropan eller terapeutisk anvendelige salte deraf DK143501C (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK364180A DK364180A (da) 1973-02-20 1980-08-25 Analogifremgangsmaade til fremstilling af betareceptorstimulerende derivater af 2-hydroxy-3-amino-propan

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH244473 1973-02-20
CH244473A CH584209A5 (en) 1973-02-20 1973-02-20 3-amino-2-hydroxypropoxy substd. diazines and pyridines - with beta-adrenergic blocking or stimulating activity
FI19374 1974-01-23
FI193/74A FI60391C (fi) 1973-02-20 1974-01-23 Analogifoerfarande foer framstaellning av beta-reseptor-aktiva 1-heterocyklyloxi-3-amino-2-propanolfoereningar

Publications (2)

Publication Number Publication Date
DK143501B DK143501B (da) 1981-08-31
DK143501C true DK143501C (da) 1982-02-22

Family

ID=25690464

Family Applications (1)

Application Number Title Priority Date Filing Date
DK80774A DK143501C (da) 1973-02-20 1974-02-15 Analogifremgangsmaade til fremstilling af beta-receptorblokerende derivater af 2-hydroxy-3-aminopropan eller terapeutisk anvendelige salte deraf

Country Status (15)

Country Link
AR (6) AR207133A1 (xx)
AT (1) AT335455B (xx)
BE (1) BE811274A (xx)
CA (1) CA1027131A (xx)
CS (1) CS203970B2 (xx)
DD (1) DD110041A5 (xx)
DE (1) DE2406930A1 (xx)
DK (1) DK143501C (xx)
ES (2) ES446081A1 (xx)
FR (1) FR2218101B1 (xx)
GB (1) GB1465946A (xx)
IE (1) IE38839B1 (xx)
IL (1) IL44202A (xx)
LU (1) LU69415A1 (xx)
SE (1) SE420834B (xx)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195090A (en) * 1973-02-20 1980-03-25 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)pyridine derivatives and pharmaceutical compositions therewith
US4000282A (en) * 1974-12-16 1976-12-28 Merck & Co., Inc. 2-(3-tert. butyl or isopropylamino-2-hydroxypropoxy)-3-cyanopyridines
JPS5283759A (en) * 1976-01-01 1977-07-12 Merck & Co Inc Substituted pyridines
US4091104A (en) * 1976-06-15 1978-05-23 Merck & Co., Inc. Substituted (3-loweralkylamino-2-R1 O-propoxy)pyridines, their preparation and use
US4092419A (en) * 1976-06-15 1978-05-30 Merck & Co., Inc. Substituted (3-loweralkylamino-2-R1 O-propoxy)pyridines, their preparation and use
US4060601A (en) * 1976-06-15 1977-11-29 Merck & Co., Inc. Certain lower-alkyl amino-2'-hydroxy-propoxy pyridines
DE2711655A1 (de) * 1977-03-17 1978-09-21 Basf Ag Pyridinyl-aminoalkylaether
US4166851A (en) * 1977-05-16 1979-09-04 Merck & Co., Inc. Certain imidazo(1,2a)pyridine derivatives
US4753673A (en) * 1977-07-22 1988-06-28 The Dow Chemical Company Trifluoromethyl pyridinyloxyphenoxy and pyridinylthiophenoxy propanoic acids and propanols and derivatives thereof and methods of herbicidal use
US4144343A (en) * 1978-01-04 1979-03-13 Merck & Co., Inc. Heterocycle substituted (3-loweralkylamino-2-R1 O-propoxy)pyridines
JPS54106476A (en) * 1978-01-04 1979-08-21 Merck & Co Inc Multiisubstituted 22*33lower alkylaminoo22 r100propoxy*pyridine
US4279913A (en) * 1978-01-04 1981-07-21 Merck & Co., Inc. Polysubstituted-2-(3-loweralkylamino-2-R1 O-propoxy)pyridines
US4210653A (en) * 1978-06-27 1980-07-01 Merck & Co., Inc. Pyridyloxypropanolamines
US4208416A (en) * 1978-06-27 1980-06-17 Merck & Co., Inc. N-Aralkyl containing cyanopyridines
DK267779A (da) * 1978-06-27 1979-12-28 Merck & Co Inc Fr&mgangsmaade til fremstilling af n-aralkylamino-propoxycyanopyridiner
US4393212A (en) * 1979-01-29 1983-07-12 Merck & Co., Inc. Certain nicotinic acid esters and corresponding nicotinonitriles
US4294969A (en) * 1979-01-29 1981-10-13 Merck & Co., Inc. Process for producing 2-bromo-3,5-disubstituted pyridines
DD150456A5 (de) * 1979-03-01 1981-09-02 Ciba Geigy Ag Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols
US4281005A (en) 1979-03-05 1981-07-28 Merck & Co., Inc. Novel 2-pyridylimidazole compounds
IT1165040B (it) * 1979-04-23 1987-04-22 Isf Spa Alcossialchilidenidrazinopiridazione e procedimento per la loro preparazione
DE2943774A1 (de) * 1979-10-26 1981-05-14 1000 Berlin Schering Ag Berlin Und Bergkamen Substituierte pyridine, verfahren zu ihrer herstellung und ihre verwendung
IL62602A (en) * 1980-05-19 1984-06-29 Labaz Sanofi Nv Pyridoxine derivatives,their preparation and pharmaceutical compositions containing them
FR2502618A1 (fr) * 1981-03-25 1982-10-01 Synthelabo Derives de pyridine, leur preparation et leur application en therapeutique
US4517188A (en) * 1983-05-09 1985-05-14 Mead Johnson & Company 1-Pyrimidinyloxy-3-hetaryl-alkylamino-2-propanols
US4598149A (en) * 1984-03-02 1986-07-01 Merck & Co., Inc. 3-amino-2-hydroxypropyl of pyrimidin-4-one useful as antihypertensive, cardioprotective, antiarrythmic, and antianginal agents
US6465467B1 (en) 1999-05-21 2002-10-15 Biovitrum Ab Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
US7361671B2 (en) * 2001-11-15 2008-04-22 The Institute For Pharmaceutical Discovery, Inc. Substituted heteroarylalkanoic acids
BR0311970A (pt) 2002-06-19 2005-03-29 Biovitrum Ab Novos compostos, seu uso e preparação
JP2006509790A (ja) * 2002-11-27 2006-03-23 アルテシアン セラピューティック,インコーポレイティド 心不全の治療のための混合されたPDE阻害およびβアドレナリン拮抗薬活性または部分的作用薬活性を有する化合物
US20080033020A1 (en) * 2004-07-23 2008-02-07 Darren Mansfield 3-Pyridinylethylbenzamide Derivatives as Fungicides
BR112012006330A2 (pt) * 2009-09-21 2017-07-04 Janssen Cilag S A análogos de o-benzil nicotinamida como moduladores alostéricos positivos de mglur5

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1001631A (en) * 1972-05-05 1976-12-14 Merck Sharp And Dohme (I.A.) Corp. 2-(3-substituted amino-2-hydroxy-propoxy)-3-substituted pyrazines and method for preparation

Also Published As

Publication number Publication date
AR203878A1 (es) 1975-10-31
ATA133074A (de) 1976-07-15
AR206801A1 (es) 1976-08-23
IE38839L (en) 1974-08-20
AR208043A1 (es) 1976-11-22
DE2406930A1 (de) 1974-08-22
ES446083A1 (es) 1977-09-16
IE38839B1 (en) 1978-06-07
CS203970B2 (en) 1981-03-31
DD110041A5 (xx) 1974-12-05
AT335455B (de) 1977-03-10
ES446081A1 (es) 1977-06-16
CA1027131A (en) 1978-02-28
AR208397A1 (es) 1976-12-27
FR2218101A1 (xx) 1974-09-13
AR214612A1 (es) 1979-07-13
DK143501B (da) 1981-08-31
LU69415A1 (xx) 1975-12-09
AR207133A1 (es) 1976-09-15
IL44202A0 (en) 1974-06-30
GB1465946A (en) 1977-03-02
BE811274A (fr) 1974-08-19
FR2218101B1 (xx) 1977-07-15
IL44202A (en) 1978-10-31
SE420834B (sv) 1981-11-02

Similar Documents

Publication Publication Date Title
DK143501C (da) Analogifremgangsmaade til fremstilling af beta-receptorblokerende derivater af 2-hydroxy-3-aminopropan eller terapeutisk anvendelige salte deraf
DK144942C (da) Analogifremgangsmaade til fremstilling af alkanophenon-o-(2-aminoethyl)-oximetherforbindelser eller deres salte
DK145339C (da) Analogifremgangsmaade til fremstilling af 4-amino-5-hexensyre eller farmaceutisk acceptable salte deraf
DK149893C (da) Analogifremgangsmaade til fremstilling af thiazolderivater eller farmaceutisk acceptable salte deraf
DK143227C (da) Analogifremgangsmaade til fremstilling af substituerede 2,2'-methylendiphenoler eller farmakologisk acceptable salte deraf
DK146538C (da) Analogifremgangsmaade til fremstilling af 7alfa-methoxycephalosporinderivater eller farmaceutisk acceptable salte deraf
DK5976A (da) Fremgangsmade til fremstilling af biphenyloxyderivater eller salte heraf
DK157246C (da) Analogifremgangsmaade til fremstilling af n-acylamino-alfa-phenylacetamidocephalosporiner eller farmaceutisk acceptable salte heraf.
DK145907C (da) Fremgangsmaade til fremstilling af 2-arylamino-2-imidazolin-derivater eller salte deraf
DK142948C (da) Analogifremgangsmaade til fremstilling af biphenylyl-acetylaminopyridiner eller fysiologisk acceptable salte heraf
DK149230C (da) Analogifremgangsmaade til fremstilling af 5-benzoyl-6-hydroxy-indan-1-carboxylsyrederivater eller farmaceutisk acceptable salte deraf
DK139580B (da) Analogifremgangsmåde til fremstilling af additionssalte af piperidylindolderivater.
DK145263C (da) Analogifremgangsmaade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf
DK143105C (da) Analogifremgangsmaade til fremstilling af aminobenzocycloheptenderivater eller farmaceutisk acceptable additionssalte deraf
DK146539C (da) Analogifremgangsmaade til fremstilling af 7alfa-methoxycephalosporin-derivater
DK127676A (da) Fremgangsmade til fremstilling af 9-alkylamino-erythromyciner eller salte deraf
DK136816B (da) Analogifremgangsmåde til fremstilling af phenoxypropylaminderivater eller af deres salte.
DK136468C (da) Analogifremgangsmade til fremstilling af 1-ethylimidazoler eller salte deraf
DK133153C (da) Analogifremgangsmade til fremstilling af tetrahydrocyklopropadibenzazepinderivater eller salte deraf
DK153837C (da) Analogifremgangsmaade til fremstilling af pyrrolderivater eller deres terapeutisk anvendelige salte
DK408176A (da) Fremgangsmade til fremstilling af 5-thiazolmethanaminderivater eller salte deraf
DK508375A (da) Fremgangsmade til fremstilling af aminoglycosidisk derivat eller additionssalte deraf
DK140841B (da) Analogifremgangsmåde til fremstilling af isoquinolinderivater eller salte deraf.
DK143844C (da) Analogifremgangsmaade til fremstilling af alkanophenon-o-(2-aminoethyl)-oximetherforbindelser eller salte deraf
DK144656C (da) Analogifremgangsmaade til fremstilling af alkylphenylbenzopyranopyridiner eller pharmaceutiske acceptable salte deraf

Legal Events

Date Code Title Description
PBP Patent lapsed